-Search query
-Search result
Showing 1 - 50 of 193 items for (author: ilves & i)
EMDB-40981:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40982:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2e:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2f:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40822:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40823:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40824:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swv:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sww:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swx:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40825:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
PDB-8sx3:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
EMDB-40242:
BG505 MD39 SOSIP in complex with Rh.NJ85 wk12 gp120GH, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40243:
BG505 MD39 SOSIP in complex with Rh.NJ86 wk12 V1V3, C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40244:
BG505 MD39 SOSIP in complex with Rh.NJ76 wk12 C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40252:
BG505 MD39 SOSIP in complex with Rh.NK04 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40254:
BG505 MD39 SOSIP in complex with Rh.NJ75 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40255:
BG505 MD39 SOSIP in complex with Rh.NJ87 wk12 C3V5 and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40256:
BG505 MD39 SOSIP in complex with Rh.NJ84 wk12 V1V3, gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40257:
BG505 MD39 SOSIP in complex with Rh.NJ77 wk12 V1V3, C3V5, N611/FP and base epitope polyclonal
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40803:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40804:
BG505 Boost2 SOSIP.664 in complex with NHP Polyclonal Antibody FP4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40805:
BG505 Boost 2 in complex with NHP antibody V1V2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40806:
BG505 Boost 2 in complex with NHP Polyclonal Antibody N625
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40807:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base1
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40808:
Boost 2 SOSIP.664 in complex with NHP polyclonal antibody Base2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40809:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40810:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sw7:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-27610:
BG505 MD39 SOSIP in complex with Rh.NJ82 wk13 N611 and base epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27611:
BG505 MD39 SOSIP in complex with Rh.NJ95 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27612:
BG505 MD39 SOSIP in complex with Rh.NK05 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27614:
BG505 MD39 SOSIP in complex with Rh.NJ79 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27615:
BG505 MD39 SOSIP in complex with Rh.NJ93 wk13 base and V5/C3 epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27601:
BG505 MD39 SOSIP in complex with Rh.K409 wk13 base, FP/gp41, V5/C3 and N611 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27602:
BG505 MD39 SOSIP in complex with Rh.K487 wk13 base, FP/gp41, and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27603:
BG505 MD39 SOSIP in complex with Rh.DGT5 wk13 base, N335/N289, V1/V3 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27604:
BG505 MD39 SOSIP in complex with Rh.K949 wk33 base, N335/N289, V1/V3, N611 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27605:
BG505 MD39 SOSIP in complex with Rh.L282 wk33 base, N335/N289, FP/gp41 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27607:
BG505 MD39 SOSIP in complex with Rh.DHHT wk33 base, FP/gp41 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27608:
BG505 MD39 SOSIP in complex with Rh.DHID wk33 base, N355/N289 and V1/V3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27609:
BG505 MD39 SOSIP in complex with Rh.NJ78 wk13 V5/C3 and base epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27600:
BG505 MD39 SOSIP in complex with Rh.L614 wk13 base, N335/N289, V5/C3 and N611 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-23778:
Negative stain EM map of BG505 SOSIP in complex with Rh4O9.8 monoclonal antibody (as Fab fragment)
Method: single particle / : Antanasijevic A, Ward AB
EMDB-23779:
BG505 SOSIP.v5.2 in complex with the polyclonal Fab pAbC-1 from animal Rh.4O9
Method: single particle / : Antanasijevic A, Ozorowski G, Nogal B, Ward AB
EMDB-23780:
BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3
Method: single particle / : Antanasijevic A, Ward AB
EMDB-23801:
BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R
Method: single particle / : Antanasijevic A, Ward AB
PDB-7mdt:
BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment)
Method: single particle / : Antanasijevic A, Ozorowski G, Nogal B, Ward AB
PDB-7mdu:
BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3
Method: single particle / : Antanasijevic A, Ward AB
PDB-7mep:
BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R
Method: single particle / : Antanasijevic A, Ward AB
Pages: